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KLF1 regulates a diverse suite of genes to direct erythroid cell differentiation from bipotent progenitors. To determine the
local cis-regulatory contexts and transcription factor networks in which KLF1 operates, we performed KLF1 ChIP-seq in the
mouse. We found at least 945 sites in the genome of E14.5 fetal liver erythroid cells which are occupied by endogenous
KLF1. Many of these recovered sites reside in erythroid gene promoters such as Hbb-b1, but the majority are distant to any
known gene. Our data suggests KLF1 directly regulates most aspects of terminal erythroid differentiation including
production of alpha- and beta-globin protein chains, heme biosynthesis, coordination of proliferation and anti-apoptotic
pathways, and construction of the red cell membrane and cytoskeleton by functioning primarily as a transcriptional
activator. Additionally, we suggest new mechanisms for KLF1 cooperation with other transcription factors, in particular
the erythroid transcription factor GATA1, to maintain homeostasis in the erythroid compartment.
[Supplemental material is available online at http://www.genome.org. The sequence data from this study have been
submitted to NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo) under accession no. GSE20478.]
Erythropoiesis, the production of red blood cells (erythrocytes), is
characterized by an intricate coordination between proliferation
and differentiation of hematopoietic stem cells into mature enu-
cleated cells (Koury et al. 2002). As differentiation proceeds, there
are well-described changes in cell surface protein expression (e.g.,
CD71 and Ter119), reduction in cell size, progressive hemoglobi-
nization, and nuclear condensation which finally results in ex-
trusion of the nucleus, RNA, and mitochondria (Cantor and Orkin
2002; Zhang et al. 2003; Testa 2004; Fraser et al. 2007). During
erythropoiesis there is also an activation of red cell–specific bio-
chemical pathways to harness energy in the absence of mito-
chondria (i.e., anaerobic glycolysis) and to generate antioxidant
small molecules to protect the red cell against oxidant stressors.
The coordination of this complex biology and biochemistry re-
mains poorly understood.
A relatively small number of transcription factors are critical
for erythropoiesis (Cantor and Orkin 2002); two of the best un-
derstood are GATA1 and KLF1 (formerly known as EKLF), which
bind to GATA (59-WGATAR-39) and extended CACC (59-CCN-
CNC-CCN-39) DNAmotifs in the promoters, enhancers, and locus
control regions (LCRs) of many erythroid genes (Weiss and Orkin
1995; Perkins 1999). Our current understanding of GATA1- and
KLF1-regulated genes has in the most part arisen from gene knock-
out studies (Pevny et al. 1991; Nuez et al. 1995; Perkins et al. 1995;
Fujiwara et al. 1996), expression profiling experiments (Welch
et al. 2004; Drissen et al. 2005; Hodge et al. 2006; Pilon et al. 2008),
and gene-by-gene promoter-reporter studies. These approaches are
likely to have elucidated only a small subset of the true direct tar-
get genes for these factors. This has become particularly evident
through recent global studies of in vivo GATA1 binding that show
it underpins extensive erythroid gene regulatory networks (Cheng
et al. 2009; Fujiwara et al. 2009; Yu et al. 2009).
KLF1 is the founding member of a family of 17 transcription
factors in mammals, which is defined by the presence of three
highly similar C2H2 type zinc fingers at the C terminus (Miller and
Bieker 1993; van Vliet et al. 2006). Expression of Klf1 is remarkably
restricted to erythroid cells and their precursors (Miller and Bieker
1993) and is critical in erythroid versus megakaryocyte lineage
choice (Starck et al. 2003; Siatecka et al. 2007; Tallack and Perkins
2010). Klf1/mice die from anemia by E15.5, with severe defects
in differentiation, hemoglobinization, enucleation, andmembrane-
cytoskeleton organization of red blood cells (Nuez et al. 1995;
Perkins et al. 1995). Direct transcriptional target genes of KLF1 are
few to date, but loss of some are likely to explain these phenotypes,
at least in part. These KLF1 target genes includeHbb-b1 (betamajor
globin), Ahsp, Epb4.9 (also known asDematin), Klf3 (also known as
Bklf ), E2f2, andCdkn2c (also known as p18INK4c) (Miller and Bieker
1993; Nuez et al. 1995; Perkins et al. 1995; Drissen et al. 2005;
Hodge et al. 2006; Pilon et al. 2006, 2008; Funnell et al. 2007; Keys
et al. 2007; Tallack et al. 2007, 2009).
At present, the best prediction of KLF1 binding site preference
has arisen from the crystal structure of the three zinc fingers of
a related protein, ZIF268 (also known as EGR1 or KROX24), bound
to is cognate DNAmotif (Feng et al. 1994). However, the extent to
which this reflects the true in vivo binding of KLF1 is not known.
Descriptions of transcription factor binding sites determined in
vitro have been shown in some cases to be information poor
compared with those defined in vivo, as is the case for the tumor
suppressor protein TRP53 (Wei et al. 2006).
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The aim of this study was to gain a better understanding of
how KLF1 regulates erythropoiesis through determination of the
sites bound by KLF1 in vivo. By employing chromatin immuno-
precipitation (ChIP) in primary fetal liver erythroid cells, coupled
with high-throughput DNA sequencing, we have described the
transcriptional networks that are underpinned by KLF1 in eryth-
ropoiesis. Additionally, by de novo motif discovery and motif
enrichment analysis we have provided insights into the coop-
eration of KLF1 with other transcription factors in vivo. In par-
ticular, we describe that KLF1 often works with GATA1 under
specific rules of engagement. Together, these results shed new light
on how erythropoiesis is programmed and how KLF1 functions
in vivo.
Results
KLF1 occupies CACC motifs located proximally and distally
to transcription start sites
In order to broaden our understanding of how KLF1 regulates
erythropoiesis, we set out to determine all of the binding sites
occupied by endogenous KLF1 in vivo. We performed ChIP-seq on
E14.5 fetal liver, a rich source of definitive erythroid cells at various
stages of maturation, to uncover a comprehensive list of direct
KLF1 target genes (Supplemental Table S1). DNA recovered from
KLF1 ChIP was used to construct fragment libraries and sequenced
with the SOLiD next-generation sequencing platform (Applied
Biosystems). We generated 17,438,921 and 47,356,494 uniquely
mapping ChIP-seq reads to the mm9 genome for KLF1 ChIP-seq
and Input DNA libraries, respectively, and performed various peak
calling approaches to estimate that between 945 and 1380 sites are
bound by KLF1 in vivo (Supplemental Table S1).
Many (;16%) of these in vivo KLF1 binding sites occur in the
vicinity (within 1 kb) of transcription start sites (TSSs), but the
majority (;52%) are located at distances of >10 kb from any
known TSS (Fig. 1A). A list of themost highly occupied sites (based
on greatest peak height) reveals well-known direct target genes
which are critical for erythroid function such as Nprl3 (also known
as Mare) (alpha-globin LCR), Alad, Gypc, and Ermap/Scianna (Table
1). However,many of these highly occupied sites are locatedwithin
or close to genes with no previously described erythroid function
or are located at vast genomicdistances fromany knowngene (Table
1; Fig. 1A).
In order to evaluate the quality of our peak calls we measured
the frequency of CACC motif occurrences in the peak sequences.
KLF1 is known to bind DNA via a CACC motif, so the peak se-
quences should contain a nonrandomly high number of CACC
motif occurrences, if the peak calls are valid. In order to obtain an
unbiased estimate of CACC motif frequency, we used the in-
dependently derived CACC motif for KLF7 (Newburger and Bulyk
2009), whose DNA-binding domain is highly similar to that of
KLF1. Using an independently derived CACC motif avoids the
problem of circularity that could arise if we instead employed
a CACC motif derived using de novo motif discovery on our peak
sequences. Wemeasured average motif affinity, using the program
AMA (Buske et al. 2010), rather than simply counting the number
of sequences that had at least one CACC motif occurrence at
a specified score threshold. By calculating average motif affinity,
we more accurately model the thermodynamic interaction of the
transcription factor with the DNA. Thus, we account for sequences
that have a highChIP-seq signal due tomultiple weak CACCmotif
occurrences.
By performing a q-value analysis (Storey and Tibshirani 2003)
applied to the AMA scores of binding regions, we estimated that
75%of sequences are bound directly via theCACCmotif. Applying
the same analysis to our 330 strongest binding regions, we estimate
that 95% of such sequences are bound via the CACC motif. The
fact that 95% of the strongest peaks are estimated to be directly
bound via the CACCmotif indicates the high quality of the ChIP-
seq data. The 75% statistic does not imply 25%of the sequences are
noise, as CACC motif presence is only one factor contributing
to binding. In particular, cooperative transcription factor binding
(T Whitington, MC Frith, and TL Bailey, in prep.) and chroma-
tin accessibility (Whitington et al. 2009) are critical to in vivo
occupancy.
By interrogating the same 330 strongest occupied sites using
the de novo pattern recognition algorithmMEME, we have refined
the KLF1 in vivo binding site preference (Fig. 1B) to 59-R-CCM-
CRC-CCN-39 (where R represents A or G and M represents A or C),
thus providing additional specificity to the ‘‘N’’ positions pre-
viously predicted from in vitro studies (Feng et al. 1994). This site
is very similar to the KLF7 binding site deposited in UniPROBE
(Newburger and Bulyk 2009) and the KLF4 binding site as de-
termined by ChIP-seq in ES cells (Chen et al. 2008) as we would
expect based upon the similarity of the amino acid sequences
at the DNA-binding domains of most KLFs. This refined KLF1
binding motif (Fig. 1B) appears in the majority of our 945 KLF1
ChIP-seq peak sequences (572/945 with a P-value threshold of
0.0001).
Denovomotif discovery usingMEMEalso uncovered aGATA-
type motif in KLF1 ChIP-seq peak regions (Fig. 1C). This motif is
almost identical to the TAL1(SCL)-GATA1 motif from the JASPAR
CORE database (TOMTOM E-value of 6.6 3 1011). This GATA-
typemotif (Fig. 1C)was frequently observed inKLF1ChIP-seq peak
sequences (279/945with a P-value threshold of 0.0001). This result
suggested an interaction between KLF1 and the TAL1(SCL)-GATA1
complex at erythroid gene promoters and other regulatory ele-
ments might be common.
KLF1 directly regulates the production of the alpha-globin
and beta-globin subunits of hemoglobin
We expected KLF1 ChIP-seq peaks would be found at the proximal
promoters of geneswithin thebeta-globin gene cluster (e.g.,Hbb-b1)
(Im et al. 2005; Keys et al. 2007) and within the beta-globin LCR
(Im et al. 2005; Shyu et al. 2006). Indeed, we observed KLF1
binding at the Hbb-b1 promoter and at HS1, HS2, HS4, and HS3
(weakly) of the beta-globin LCR (as defined inHardison et al. 1997)
(Fig. 2B). In each of these cases there is concomitant occupancy of
GATA1, as determined by ChIP-seq in G1-ER cells (Cheng et al.
2009), suggesting the two factors cooperate at each of these cis-
regulatory elements (Fig. 2B).We also determined KLF1 occupancy
within the alpha-globin gene cluster at sites corresponding to HS-
31, HS-26, HS-21, HS-8, and an intergenic site between the Hbq2
(also known as F830116E18Rik) and Hba-a1 genes (Fig. 2A). KLF1
occupancy at HS-26 has been observed previously (Vernimmen
et al. 2007); however, this is the first report of occupancy at addi-
tional DNase I hypersensitive sites in the alpha-globin gene cluster.
Again, we observed concomitant occupancy of GATA1 at all of
these sites consistent with cooperation between these two factors
in regulation of the alpha-globin gene cluster (Fig. 2A). In partic-
ular, the peak of KLF1 binding at HS-26 (corresponding to HS-40 in
humans) has a high tag count suggesting strong affinity (Table 1).
These observations suggest KLF1 is a transcriptional regulator of
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both the alpha- and beta-globin loci and may coordinate the bal-
anced production of globin chains. It also provides further vali-
dation of our ChIP-seq data set and peak calling specificity.
Heme synthesis and iron procurement are directly
coordinated by KLF1
Our study demonstrated KLF1 occupancy at many (;2/3) of the
genes that are required to produce enzymes of the heme synthesis
pathway (Ponka 1997), or those required for iron procurement
(Fig. 3A; Dunn et al. 2007). Remarkably themajority of the genes in
the heme synthesis pathway have KLF1 ChIP-seq peaks at their
promoters, within introns (often the first intron) or in neighboring
intergenic regions (Fig. 3A; Supplemental Fig. S2; Supplemental
Table S2). In order to confirm that occupancy coincided with ex-
pression of each of these genes, we performed qRT-PCR of some
of these heme synthesis–related genes in wild-type (WT) versus
Klf1/ fetal liver (Fig. 3B). All of the genes that we tested with the
exception of Uros and Fech, which do not contain KLF1 ChIP-seq
peaks, have decreased expression in Klf1/ fetal liver compared
with WT. Some of these genes appear to produce erythroid spe-
cific transcripts (e.g., Alad-e, Hmbs/Pbgd-e, Tspo-e) which are also
Figure 1. KLF1 ChIP-seq reveals a role in both proximal and distal gene regulation and a refined in vivo binding site motif. (A) Characteristics of KLF1
binding with respect to transcriptional start sites (TSSs). Distances between all KLF1 ChIP-seq peak sites and the nearest mm9 UCSC Genome Browser
annotated TSS were determined and sorted into upstream and downstream sets as shown. Distances are plotted as a histogram on a Log10 scale (e.g.,
3 represents 1000 bp). (B) KLF1 in vivo consensus binding site predicted by themotif discovery algorithmMEME 4.3 and presented as a sequence LOGO. (C )
Analysis of KLF1ChIP-seq peaks withMEME4.3 also uncovered themotif shownherewhich strikingly resembles themotif formurine TAL1(SCL)-GATA1 from
the JASPAR CORE database (TOMTOM E-value = 6.6 3 1011).
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specifically reduced at the mRNA level in Klf1/ erythroid tissue
(Fig. 3B).
KLF1 also appears to regulate importation of coproporphyri-
nogen III (COPRO) into the mitochondria where ferrous iron can
be safely incorporated into heme (Fig. 3A). This process is regulated
by a recently described multiprotein complex known as the mi-
tochondrial permeability transition pore (MPTP) complex (Fig. 3A,
inset; Papadopoulos et al. 2006). KLF1 binds with GATA1 to the
promoters of two genes, Bzrap1 and Vdac1, which encode proteins
that contribute to the MPTP (Fig. 3A; Supplemental Fig. S2).
Many of the genes required for iron transport have been dis-
covered only recently, and more are likely to await discovery
(Dunn et al. 2007). We have known for many years that surface
expression of the transferrin receptor (Tfrc, CD71) on erythroid
cells is reduced in the absence of Klf1 in a gene dosage-dependent
manner, suggesting it might be a direct target of KLF1 (Hodge et al.
Table 1. Highest ranking KLF1 ChIP-seq peaks
Peak
height
Genomic location
(mm9)
Nearest gene
symbol
Nearest gene
name
Previously identified
target
Peak
position
57 Chr17:35878969-35878969 Ddr1 Discoidin domain receptor family, member 1 Intergenic
47 Chr6:72229669-72229671 Sftpb Surfactant associated protein B Intergenic
47 Chr8:19984277-19984280 6820431F20Rika RIKEN non-coding RNA Other intronic
44 Chr17:26651596-26651596 Dusp1 Dual specificity phosphatase 1 Intergenic
42 Chr14:70866215-70866217 Phyhip Phytanoyl-CoA hydroxylase interacting protein Other intronic
37 Chr16:8655920-8655920 Pmm2 Phosphomannomutase 2 Other intronic
36 Chr15:85935903-85935904 Gramd4 GRAM domain containing 4 Other intronic
35 Chr11:32151066-32151067 Nprl3/Mare Alpha globin regulatory element containing (Vernimmen
et al. 2007)
Other intronic
35 Chr3:103708832-103708836 Ptpn22 Protein tyrosine phosphatase, non-receptor type 22 Other intronic
35 Chr4:62177796-62177808 Alad Aminolevulinate, delta-, dehydratase Intron 1
34 Chr1:36148310-36148311 Hs6st1 Heparan sulphate 6-O-sulfotransferase 1 Intron 1
34 Chr15:80591622-80591622 Tnrc6b Trinucleotide repeat containing 6b isoform 1 Other intronic
34 Chr18:32702272-32702272 Gypc Glycophorin C (Hodge et al. 2006) Intron 1
34 Chr4:151100744-151100749 Camta1 Calmodulin binding transcription activator 1 Other intronic
34 Chr4:151334799-151334802 Dnajc11 DnaJ homolog, subfamily C, member 11 Other intronic
33 Chr17:29067432-29067432 Pxt1 Peroxisomal testis-specific protein 1 Intergenic
32 Chr15:56455310-56455316 Has2 Hyaluronan synthase 2 Intergenic
31 Chr17:26079773-26079775 Pigq Phosphatidylinositol N-acetylglucosaminyltransferase
subunit Q
Promoter
31 Chr4:34497718-34497723 Akirin2 Akirin2 Promoter
31 Chr8:126512748-126512749 Abcb10 ABC mitochondrial erythroid Intergenic
30 Chr4:118862630-118862630 Ermap Erythroid membrane-associated protein (Hodge et al. 2006) Promoter
30 Chr5:65256112-65256116 Klf3 Kruppel-like factor 3 (Funnell et al. 2007) Intergenic
30 Chr6:86028020-86028021 Add2 Adducin 2 Promoter
29 Chr1:137838412-137838414 Igfn1 Immunoglobulin-like and fibronectin type III
domain-containing protein 1
Intergenic
29 Chr10:40726672-40726673 Gpr6 G protein-coupled receptor 6 Intergenic
29 Chr4:124283662-124283662 Pou3f1 POU domain, class 3, transcription factor 1 Intergenic
29 Chr4:135734089-135734108 E2f2 E2f transcription factor 2 (Pilon et al. 2008;
Tallack et al. 2009)
Intron 1
29 Chr5:139673057-139673057 Unc84a Unc-84 homolog A Promoter
29 Chr8:107824107-107824107 E2f4 E2f transcription factor 4 (Tallack et al. 2009) Intronic
29 Chr8:24164688-24164690 Ank1 Ankyrin 1 (Nilson et al. 2006) Intron 1/
promoter
28 Chr10:41632340-41632340 Armc2 Armadillo repeat containing 2 Intergenic
28 Chr12:112797042-112797043 Eif5 Eukaryotic translation initiation factor 5 Intergenic
28 Chr2:103962300-103962302 A930018P22Rik RIKEN cDNA for hypothetical protein LOC68243 Promoter
28 Chr2:125973640-125973654 4930525F21Rik RIKEN cDNA for hypothetical protein LOC75823 Promoter
27 Chr10:111262060-111262060 Krr1 HIV-1 Rev binding protein 2 Intergenic
27 Chr13:112833977-112833981 Map3k1 Mitogen-activated protein kinase kinase kinase 1 Intergenic
27 Chr17:12397892-12397892 Agpat4 1-acylglycerol-3-phosphate O-acyltransferase 4 Other intronic
27 Chr17:25039865-25039870 Mapk8ip3 Mitogen-activated protein kinase 8 interacting Other intronic
26 Chr11:104890558-104890569 Efcab3 EF-hand calcium binding domain 3 Intergenic
26 Chr14:69923035-69923039 D930020E02Rik Envelope glycoprotein syncytin-B Intergenic
26 Chr17:29575527-29575538 Pim1 Proviral integration site 1 Intergenic
26 Chr2:164599599-164599600 Ube2c Ubiquitin-conjugating enzyme E2C (Hodge et al. 2006) Intergenic
26 Chr2:172116029-172116043 Mc3r Melanocortin 3 receptor Intergenic
26 Chr4:143002576-143002578 Pramef8 PRAME family member 8 59 UTR
26 Chr9:108243328-108243330 Gpx1 Glutathione peroxidase 1 Intergenic
26 Chr9:66351957-66351962 Herc1 Hect domain and RCC1-like domain 1 Other intronic
25 Chr13:114606283-114606286 Arl15 ADP-ribosylation factor-like 15 Intron 1
25 Chr13:35769443-35769443 Cdyl Chromodomain protein, Y chromosome-like Other intronic
25 Chr15:78243638-78243639 Mpst Mercaptopyruvate sulfurtransferase Other intronic
25 Chr6:88586555-88586556 Kbtbd12 Kelch repeat and BTB domain containing 12 Intergenic
25 Chr7:128851130-128851134 Usp31 Ubiquitin specific peptidase 31 Promoter
25 ChrX:39372687-39372688 Xiap X-linked inhibitor of apoptosis Intergenic
aThe 6820431F20Rik peak appears to be an artifact of chromatin conformation. This is further discussed in Supplemental Figure S1.
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2006). We therefore asked whether KLF1 directly regulates either
of the two transferrin receptor genes (Tfrc1 [also known asTfrc] and
Tfrc2) and other genes involved in trafficking of iron from the re-
ceptor to the hememolecule insidemitochondria (Fig. 3A). Indeed
we found KLF1 ChIP-seq peaks in the vicinity of Tfrc1, the mito-
chondrial iron transporter mitoferrin (Slc25a37), and the Slc11a2
and Steap3 genes which encode proteins involved in iron transport
and its reduction in the endosome (Fig. 3A). Additionally, Slc25a37
is markedly down-regulated in the Klf1/ fetal liver (Fig. 3B).
The final step in the assembly of the hemoglobin molecule
requires a fully constructed iron containing heme group to be
transported outside of the mitochondria and coordinated with the
appropriate globin protein chains (Fig. 3A). KLF1 additionally ap-
pears to control this process by direct regulation of the Abcb10
(ABC-me) and Abcg2 genes that produce heme exporter proteins
(Fig. 3A). Previous studies have also described KLF1 as a critical
regulator of the gene encoding the alpha-globin chaperone protein
Ahsp (Pilon et al. 2006; Keys et al. 2007). Unfortunately the Ahsp
gene is missing from the mm8 and mm9 genome assemblies,
preventing its inclusion in the comprehensive list of KLF1 ChIP-
seq target genes reported in this study.
We chose to validate that the heme synthesis–related genes
with strong KLF1 ChIP-seq peaks (red boxes, Fig. 3A) were directly
induced by KLF1 in a Klf1/ erythroid cell line with tamoxifen-
inducible KLF1 activity (Fig. 3C; Coghill et al. 2001). This system
facilitates testing of direct chromatin-dependent induction of gene
expression and is more physiological than reporter assays with
plasmids (Coghill et al. 2001; Brown et al. 2002).We compared the
induction of these genes (Alad, Slc25a37, and Abcb10) to that of
beta-globin (Hbb-b1). We found beta-globin to be strongly induced
(;50-fold by 14 h) by tamoxifen in these cells as expected (Keys
et al. 2007). We also found Alad-e (erythroid specific transcript of
Alad) and Slc25a37 to be rapidly induced by tamoxifen, albeit at
levels much lower than for beta-globin (approximately sixfold and
approximately threefold, respectively). Expression of Abcb10 was
only mildly induced by tamoxifen in these cells (;1.5-fold), al-
though these cells do not fully differentiate as erythroid cells do in
vivo. These observations confirm that KLF1 is a critical direct reg-
ulator of many genes acting throughout the production of he-
moglobin, from heme synthesis to iron procurement to the as-
sembly of hemoglobin itself.
KLF1 regulates erythroid cell survival, proliferation,
and integrity by direct regulation of specific target genes
The site of additional KLF1 ChIP-seq peaks provided us with an
interesting insight into other processes that were likely to be con-
trolled by KLF1 activity. We found peaks within the genes Bcl2l1
(Bcl-X ), Xiap, and Pim1, which are known to be anti-apoptotic,
prosurvival components of erythroid cells (Supplemental Fig. S3).
We also confirmed our previous identification of E2f2 as a direct
KLF1 target gene via an enhancer located in the first intron (Tallack
et al. 2009); however, we were unable to identify KLF1 binding at
the gene promoter (Supplemental Fig. S4). Additionally we deter-
mined a region of strong KLF1 occupancy in intron 5 of the E2f4
gene (Supplemental Fig. S4).Wepreviously couldnot identify KLF1
binding to this region in K1-ER cells that have been retrovirally
immortalized (Tallack et al. 2009). However, the use of primary
tissue for ChIP-seq in this case provides evidence that E2f4 is in-
deed a direct KLF1 target gene. Further KLF1 target genes that play
roles in the maintenance and integrity of the erythroid cell mem-
brane and cytoskeleton such as the Ermap (Ye et al. 2000), glyco-
phorin C (Gypc), and ankyrin 1 (Ank1) (Nilson et al. 2006) genes
were uncovered (Fig. 4B; Supplemental Fig. S4). Also, KLF1
Figure 2. KLF1 binds the mouse alpha- and beta-globin loci at proximal promoters and locus control regions. (A) An image of the murine alpha-globin
gene cluster and the upstream locus control region regulatory element (HS-31 to HS-8) from the UCSC Genome Browser. Genes and DNase I hyper-
sensitivity (HS) sites are represented in the top track. KLF1 ChIP-seq signal (maroon) and Input ChIP-seq signal (blue) tracks are also shown together with
KLF1 peak calls (KLF1 Peaks). An additional track describing GATA1 ChIP-seq peak calls from Cheng et al. (2009) is shown (GATA1 Peaks) together with
a mammalian conservation track (Mammal Cons). (B) An image of the murine beta-globin gene cluster and locus control region flanked by olfactory
receptor genes from the UCSC Genome Browser. Genes and DNase I HS sites are represented in the top track. Other tracks are presented as for A.
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occupies the Fn3k, Slc2a4, and Pigq genes (Table 1; Fig. 4B) sug-
gesting a direct role in sugar metabolism and protein modification
such as glycosylation and GPI biosynthesis. In short, our study
shows that KLF1 directly regulates virtually all processes necessary
for the production and survival of erythroid cells.
KLF1 acts primarily as a transcriptional activator in vivo
and not exclusively via promoter regions
Our qRT-PCR experiments only permitted testing of a small frac-
tion of the set of KLF1-bound genes for KLF1-dependent changes
Figure 3. KLF1 directly regulates synthesis of heme and procurement of iron. (A) Schematic diagram of an erythroid cell simplistically depicting the
pathways of heme synthesis, iron procurement, heme export, and hemoglobin assembly. Genes are shown in italics at their point of involvement in the
pathways. The components of the mitochondrial permeability transition pore (MPTP) complex are shown in the inset for clarity. Genes in the figure are
color coded as shown in the peak height key according to peak height from KLF1 ChIP-seq. (B) Relative gene expression in Klf1/ fetal liver (compared
with WT) for many of the genes depicted in A. Gene expression as determined by qRT-PCR is normalized to the housekeeping gene Hprt and shown for
Klf1/ fetal liver relative to WT (set to 1 as shown by the red dotted line). Data are presented as mean 6 SEM. n $ 4 in each instance. (C ) Relative gene
expression in 4-hydroxytamoxifen (Tam)–induced K1-ER cells at 0, 3, 7, and 14 h following induction. Gene expression has been determined by qRT-PCR
and normalized to the housekeeping geneHprt. Induced gene expression (Tam,maroon) is shown together with the corresponding vehicle control (EtOH,
blue) on a Log2 scale. Data are presented as mean 6 SEM, n = 4.
KLF1 erythroid regulatory networks
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in expression. Thus, we compared our KLF1ChIP-seq data with the
KLF1 expression profiling data of Hodge et al. (2006), to elucidate
the relationship between KLF1 binding and gene activation or re-
pression, on a global scale. Microarray-probed genes were divided
into three groups: ‘‘down-regulated’’ in the Klf1/ fetal liver
(inferred to be KLF1 activated, 730 genes), ‘‘up-regulated’’ in the
Klf1/ fetal liver (inferred to be KLF1 repressed, 369 genes), or
‘‘nonresponsive’’ to loss of Klf1 (12,349 genes). We recorded the
presence of KLF1 ChIP-seq peaks in the promoter (within 2 kb of
TSS), first intron, intragenic region, and proximal downstream
region (within 2 kb of transcript end) of each gene (shown by the
cartoon in Fig. 4A). Figure 4A displays a barplot indicating the
fraction of regions that are estimated as bound, for each (respon-
siveness, region) combination. A much larger fraction of ‘‘down-
regulated’’ genes are bound by KLF1, compared with the ‘‘up-reg-
ulated’’ or ‘‘nonresponsive’’ genes. This supports the view that
KLF1 primarily activates gene expression. In contrast, there is no
significant difference between the fraction of ‘‘up-regulated’’ genes
bound and the fraction of ‘‘nonresponsive’’ genes bound, for any
gene interval. Thus, we conclude that KLF1 rarely functions as
a direct transcriptional repressor in vivo. The genes that are
bound by KLF1 and ‘‘down-regulated’’ (64 genes) in Figure 4A
(maroon bars) provide a very high confidence subset of direct
KLF1 target genes for future studies. These are provided in Sup-
plemental Table S3.
We were not surprised to observe that a high proportion of
the ‘‘down-regulated’’ genes (presumably activated by KLF1) were
not bound within their promoter region but were in fact bound at
sites within the first intron or at other intragenic regions (Fig. 4A).
For example, Alas2, Alad, Hmbs, Urod, Abcg2, Slc11a2, Bcl2l1, and
Ank1 all have KLF1 binding sites in the first intron (Supplemental
Figs. S2, S3, and S4 and Supplemental Table S4). This result sup-
ports the notion that KLF1 might be activating transcription of
target genes at alternative erythroid specific promoters (either
known or supported by mRNA, EST, or CAGE data, Supplemental
Table S4) in many cases, or via intronic enhancer elements, as for
E2f2 and E2f4 (Tallack et al. 2009).
We also investigated the possibility that the strength or fre-
quency of KLF1 binding (peak height) to the regulatory element
of a gene might relate to the degree to which that gene is activated
by KLF1. We hypothesized that the genes which are most ‘‘down-
regulated’’ in the absence of KLF1 might contain the strongest
peaks. However, we found no relationship between strength of
binding and degree of responsiveness to KLF1 (Fig. 4B). Indeed
some of the most ‘‘down-regulated’’ genes have only modest peak
heights (e.g., Epb4.9, Fig. 4B). Likewise, some of the strongest peaks
occur in genes that are only modestly ‘‘down-regulated’’ in the
Hodge et al. (2006) data set (e.g., Gypc, Fig. 4B). However, in many
cases it is difficult to assign a peak to a TSS, since for distal peaks the
nearest TSS is often not the true target gene. Nevertheless, our
study clearly shows that KLF1 binding leads to activation of target
gene expression, but the degree to which gene activation occurs
depends on many additional factors besides the binding of this
single transcription factor.
KLF1 and GATA1 co-occupy many sites in the erythroid
genome in a distinct nonrandom configuration
Previous work has suggested cooperation between KLF1 and
GATA1 in erythroid gene regulation (Merika and Orkin 1995;
Gregory et al. 1996). However, KLF1has not been foundwithGATA1
containing protein complexes in vivo (Rodriguez et al. 2005), and
we have never been able to coimmunoprecipitate KLF1 andGATA1
in the absence of DNA. Nevertheless, to investigate a functional
DNA-dependent interaction between KLF1 and GATA1 at a global
level we took advantage of a recent ChIP-seq study performed by
Cheng et al. which defined the full complement of GATA1 binding
sites in G1-ER cells (Cheng et al. 2009). We determined the dis-
tance to the nearest GATA1ChIP-seq peak for all of our KLF1 ChIP-
seq peaks by performing a liftOver of GATA1 ChIP-seq peaks onto
the mm9 genome (see Methods). A histogram of these distances
shows that ;48% of our KLF1 ChIP-seq peaks have a correspond-
ing GATA1 ChIP-seq peak within 1 kb (Log103) (Fig. 5A, Shared),
Figure 4. KLF1 acts primarily as a direct activator of target genes and
not exclusively via promoter regions. (A) Each of the genes from the
Hodge et al. (2006) expression profiling study were classified as ‘‘down-
regulated’’ in Klf1/, ‘‘up-regulated’’ in Klf1/, or nonresponsive, when
compared with WT expression. The plot shown represents the fraction of
regions in the genes from each of these groups containing a KLF1 ChIP-seq
peak binned into categories as shown in the cartoon underneathwhere the
size of the promoter and 39 region are each 2 kb. Each error bar represents
the 95% confidence interval for the given fraction, assuming the number
of regions with a peak follows a binomial distribution with N equal to the
number of regions of that class. Note genes consisting of a single exon do
not contribute to the intragenic region calculation. (B) A plot describing
the relationship between fold change in expression in Klf1/ fetal liver
compared withWT for genes that are ‘‘bound’’ by KLF1 within the gene or
2 kb on either side. The down-regulated in Klf1/ fetal liver gene set is
shown (i.e., genes represented by maroon bars in A). The genes repre-
sented by some of the points are shown for clarity.
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suggesting in vivo cooperation between the two factors is likely.
GATA1 is known to function together with the transcription
factor SCL/TAL1 (hereafter SCL) to form an activating complex
(Tripic et al. 2009). Our de novo motif discovery (Fig. 1C) sug-
gested that a complex containing KLF1, GATA1, and SCL might
be present in erythroid cells. However, it was interesting to find
that by incorporating in vivo erythroid ChIP-seq data for SCL
(Wilson et al. 2009) into our analysis we find that KLF1-GATA1
and SCL-GATA1 cobound regions show very little overlap in vivo
(Fig. 6; Venn diagram). The SCL ChIP-seq data set may not be
comprehensive; nevertheless most SCL-bound sites are not
bound by KLF1.
Although KLF1 and GATA1 can act synergistically at artificial
promoters in reporter assays (Merika andOrkin1995), co-occupancy
of KLF1 and GATA1 in vivo does not necessarily indicate co-
operation. So we next sought to determine if there were particular
‘‘rules of engagement’’ that might provide evidence for such a func-
tional interaction. We used the algorithm SpaMo (T Whitington,
MC Frith, and TL Bailey, in prep.) to determine whether CACC and
GATA motifs exhibited any preferred spatial configuration in the
KLF1 ChIP-seq peak sequences. SpaMo produces two histograms
indicating the frequency of each possible displacement between the
two input motifs. These histograms (one for same strand motif hits,
one for opposite strand motif hits) clearly demonstrate an enrich-
ment for CACC-GATA motif displacement at 15–45 bp apart on
opposite strands (Fig. 5B). SpaMo did not detect enriched spacing
for any non-GATAmotifs in our set of 259
input motifs. This supports the veracity of
the observed CACC-GATA enrichment in
KLF1 ChIP-seq peak sequences.
The most highly represented dis-
placement between CACC and GATA
motifs is at a distance of 18 bp apart on
opposite strands. We used this infor-
mation to construct a 3D model of co-
operative binding, by placing the crystal
structures for the zinc finger domains of
GATA1 (pink) and Zif268 (a surrogate for
KLF1, blue) onto a short segment of DNA
(Fig. 5C). We have no knowledge of the
structure of the non–DNA-binding do-
mains of either KLF1 or GATA1, but we
speculate that the non–DNA-binding
domains of KLF1 and GATA1 as well as
cofactors are likely to exist in the center of
the space between the CACC and GATA
sites (Fig. 5C). Based on our de novomotif
discovery analysis with MEME, which
recovered an SCL-GATA1 site in KLF1
ChIP-seq peak regions (Fig. 1C) and the
preferential orientations of CACC and
GATAmotifs, we suggest that SCL is likely
to be one factor at the center of the KLF1-
GATA1 erythroid complex in a small
subset of erythroid cis-regulatory mod-
ules (Fig. 5C).
Transcription factor partners for KLF1
Our discovery of an interaction between
KLF1 and GATA1 at a large number of
genomic sites prompted us to ask what
other factors might also participate at these sites, and more im-
portantly, what interactions might be at play for KLF1 exclusive
sites (i.e., those with no GATA1 binding). We utilized the motif
enrichment analysis tool Clover to interrogate all KLF1-bound
genomic locations as well as KLF1-GATA1 cobound genomic lo-
cations for overrepresentation of specific known DNA motifs
(see Methods). We found an overrepresentation of GATA and
KLF motifs in both the total KLF1-bound regions and cobound
regions as expected (Fig. 6). More interestingly we found enrich-
ment of an AP-1–type motif (represented by TCF11-MafG bZIP
[Johnsen et al. 1998]) and Smad (represented by Smad3) motifs in
both types of regions (Fig. 6). Overrepresentation of a number of
other motifs was also observed, including a FORKHEAD motif
(FOXC1 FORKHEAD) and a homeobox half site motif, TAAT (Ubx
HOMEO, Fig. 6). Taken together, these results suggest that KLF1
may interact in transcriptional complexes that also include pro-
teins capable of binding to AP-1, Smad, and homeoboxmotifs (see
Discussion).
Discussion
We have described in this study a broad repertoire of direct KLF1
target genes that regulate virtually all processes associated with
erythropoiesis. Depending on the specificity of our peak callingwe
declare between 945 and 1380 in vivo KLF1 binding sites in ery-
throid cells. We have deliberately favored high specificity over
Figure 5. Correlation with GATA1 ChIP-seq reveals extensive co-occupancy by KLF1 and GATA1
throughout the erythroid genome. (A) A histogram of the distance between all KLF1 ChIP-seq peaks and
the nearest GATA1 ChIP-seq peak as determined by Cheng et al. (2009) plotted on a Log10 scale as for
Figure 1A. The bimodal distribution of distances indicates shared and unique binding sites for KLF1 as
shown. (B) Histogram plots of the distance between the KLF1motif and GATA1motifs in the same (same
strand, top) and opposing (opposite strand, bottom) directions for the KLF1 ChIP-seq peaks. (C ) Amodel
for KLF1-GATA1 cooperation based on the data presented in B. Crystal structures of the GATA1 DNA-
binding zinc fingers and Zif268 (representative of KLF1) imposed onto a DNA backbone are shown in
pink and blue, respectively. The preferred directions and spacing of the motifs for cooperation is shown.
The hypothesized existence of SCL between the two factors binding to a ‘‘CTG’’ motif is indicated in
gray.
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sensitivity in our peak calling approach to reduce the risk of de-
claring false-positive KLF1 binding sites. Thus, much greater se-
quencing depth is likely to find a small number of additional lower
affinity sites, but will mostly resequence the same high affinity
sites. These declared binding sites describe the majority of the ge-
nome wide transcriptional regulatory activities of KLF1 during
erythropoiesis.
In the vicinity of our declared KLF1 ChIP-seq peaks we iden-
tified by de novo motif discovery a SCL-GATA1 binding motif
suggesting that these two factors might interact with KLF1 to drive
the appropriate expression of erythroid genes (Fig. 1C). In addi-
tion, by using the newly developed tool SpaMo we identified a set
of specific constraints governing the positioning between CACC
and GATA motifs in KLF1 ChIP-seq peaks (Fig. 5B,C). SCL is likely
to bind between KLF1 and GATA1 in some instances, yet when
we consider the overlap between KLF1-GATA1 shared peaks and
SCL-GATA1 cobound regions it is onlyminimal (Fig. 6).We believe
that the high specificity and relatively low sensitivity of the SCL
ChIP-seq data set might partly explain for this apparent contra-
diction, whereby a less stringent peak calling approach in the SCL
ChIP-seq data set would likely lead to a greater number of peaks
and more significant overlap with KLF1 ChIP-seq peaks. Never-
theless, many SCL-GATA1–bound regions in the genome function
independently of KLF1 and vice versa.
Additionally, our study suggests there is a significant advan-
tage in using primary tissue rather than engineered cell lines for
identifying all sites of binding in vivo. For example, we previously
conductedChIP experiments in an immortalized Klf1/ erythroid
cell line with inducible KLF1 activity (K1-ER cells) and were unable
to find any binding of KLF1 at the E2f4 gene locus (Tallack et al.
2009). In direct contrast we describe here that the E2f4 gene locus
is robustly bound by KLF1 in primary fetal liver cells at a site
located within intron 5 (Supplemental Fig. S4). This is likely due
to KLF1 occupying different regions of the genome as an erythroid
precursor differentiates into a mature late normoblast. Both E2F2
and E2F4 have roles in erythroid differentiation, perhaps balanc-
ing proliferation with differentiation (Kinross et al. 2006; Dirlam
et al. 2007). Such dynamic changes in occupancy are sometimes
difficult to observe in most cell lines. This is an example of a
binding event we missed in K1-ER, and would probably miss in
MEL cell lines, that we believe highlights the advantage of per-
forming ChIP-seq experiments in primary tissue when it is possible.
We also describe a set of cis-elements we have associated with
KLF1 target genes (Table 1) that significantly overlaps with that
previously postulated from expression profiling experiments (Fig.
4) (Drissen et al. 2005; Hodge et al. 2006; Pilon et al. 2008). This
includes not only genes we might have expected to find such as
those responsible for the production of hemoglobin (Figs. 2, 3) and
the integrity and deformability of the red cell (Supplemental Fig.
S4), but also genes required for cell survival and nuclear conden-
sation like Bcl2l1, Xiap, and Pim1 (Supplemental Fig. S3). Thus it
appears that KLF1 (together withGATA1 50%of the time) regulates
virtually all of the processes at work to produce and maintain
erythroid cells.
In addition to the discovery of a new suite of KLF1 target
genes, we have also produced evidence to suggest uniquemodes of
gene regulation by KLF1.We noticed that the vastmajority of KLF1
binding sites (peaks) are located at large genomic distances from
known transcription start sites (Fig. 1A). Many of these sites have
high tag counts (strongly bound) and many are co-occupied by
GATA1. KLF1 has recently been described as a critical looping
factor particularly in the context of the beta-globin locus (Drissen
et al. 2004). It has also been shown very recently that KLF1 is
critical in the formation of nuclear transcription factories con-
sisting of RNA pol II and highly transcribed erythroid genes
(Schoenfelder et al. 2010). These studies strongly suggest that KLF1
is not only capable of, but necessary for, long-distance gene regu-
lation within erythroid cells. We suggest many of the in vivo
binding sites for KLF1 that are found at vast distances from any
known gene might function in chromatin looping, or be involved
in recruiting genomic regions into transcription factories, andmay
not function as canonical enhancers. However, we cannot be sure
that these binding sites are not functional as very distant en-
hancers. In such cases it is very difficult to know which gene(s)
might be responsive to such a putative enhancer, making func-
tional testing extremely difficult.
We also determined that for direct KLF1 target genes, regu-
lation of transcription was frequently occurring via binding at
intragenic regions, the first intron in particular (Fig. 4A; Supple-
mental Figs. S2–S4). Some of these instances are previously reported
alternative erythroid-specific promoters, others have supporting
EST evidence for alternative promoters (Supplemental Table S4),
but many have not yet been discovered. Erythroid cells have
a unique metabolic demand and appear to have coevolved
a unique set of promoters together with KLF1 so that the coding
outputs of many genes in general biochemical pathways can be
specifically tailored to the particular metabolic needs of erythroid
cells. Further studies describing the comprehensive transcriptional
landscape of erythroid cells will need to be performed to validate
this hypothesis.
In addition to the KLF1-GATA1 interaction, we have un-
covered enrichment of several transcription factor DNA-binding
motifs in the vicinity of KLF1 occupied sites that suggest the in-
volvement of transcription factors capable of binding to AP-1 like
Figure 6. Analysis of KLF1- and GATA1-bound genomic regions reveals
potential interacting transcription factor partners. A schematic represen-
tation of the overlap between KLF1, GATA1 (Cheng et al. 2009) and SCL
(Wilson et al. 2009) erythroid ChIP-seq datasets defines two major groups
of KLF1 binding sites, total binding sites (945), and shared KLF1-GATA1
binding sites (397). Interrogation of binding site sequences using the
Clover algorithm identifies the motifs shown as being overrepresented in
the groups shown at 0.05 and 0.1 P-value significance levels.
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(TCF11-MafG bZIP), Smad (Smad3), and Homeobox (Ubx HOMEO)
motifs (Fig. 6). The AP-1-like motif (TCF11-MafG bZIP [ Johnsen
et al. 1998]) is most likely bound by bZIP heterodimers like p45-
NFE2/p18-MAF which are important in erythropoiesis (Andrews
et al. 1993; Kotkow and Orkin 1995; Johnsen et al. 1998). In-
terestingly a member of the Smad family of transcription factors,
Smad5, is partly responsible for the induction of Klf1 expression
in erythroid cells (Lohmann and Bieker 2008). Smad5 continues
to be expressed in erythroid cells and is critical for the proper ex-
pansion of erythroid progenitors in the fetal liver and in stress
erythropoiesis (Porayette and Paulson 2008). In addition, our data
suggest KLF1 cooperates directlywith ‘‘ventral’’ Smads such aswith
Smad1/5/8 to mediate erythroid expansion in response to BMP4
signaling. This hypothesis is consistent with experiments per-
formed in Xenopus which show the KLF1-like protein, Klf17 (also
known as Neptune), is essential for BMP4 induction of red blood
cell formation (Huber et al. 2001). In short, we suggest Smad5 ac-
tivates KLF1 gene expression and then works with KLF1 in the
nucleus to regulate the erythroid response to stress.
In summary, our studyhas described the in vivoDNA-binding
activities of KLF1 by performing primary erythroid tissueChIP-seq.
We have revealed a complex interaction between KLF1 andGATA1
that is responsible for regulating the expression of erythroid genes,
and we provide future challenges and considerations for the in-
terpretation of ChIP-seq studies particularly with regard to eryth-
ropoiesis.
Methods
Primary fetal liver ChIP
ChIP assays were performed as previously described (Hodge et al.
2006) using a rabbit polyclonal antibody raised against the N ter-
minus of KLF1 (Perkins et al. 1995; Keys et al. 2007) in Klf3/ or
wild-type (WT) fetal livers collected from E14.5 mouse embryos.
At this stage of development the fetal liver is entirely erythroid
and composed of cells at various stages of maturation from pro-
erythroblasts to late enucleating normoblasts. Klf3/ fetal livers
were utilized in addition to WT due to anticipated stronger KLF1
ChIP occupancy based on a recently proposed model of competi-
tion between KLF1 and KLF3 (BKLF) for CACC box occupancy in
vivo (Eaton et al. 2008). In brief, ChIP assays were performed on
pools of four homogenized E14.5 fetal livers (;8 3 107 cells) and
validated by quantitative real-time PCR as previously described
to determine occupancy at an E2f2 enhancer (E2f2-i1en) and the
Ahsp promoter (Keys et al. 2007; Tallack et al. 2009).
ChIP-seq library construction
The SOLiD System 2.0 workflow for Lower Input/Lower Com-
plexity DNA fragment library preparation (Applied Biosystems)
was followed to prepare libraries containing 80–130 bp of ChIP
DNA (or Input DNA) flanked by the appropriate adaptors. A detailed
description of themethod is provided in the SupplementalMethods.
SOLiD chemistry sequencing
SOLiD ChIP-seq DNA fragment libraries were sequenced by SOLiD
system 2.0 and SOLiD system 3.0 chemistries to produce DNA
sequence reads of 35 and 50 nucleotides (nt), respectively. Se-
quencing readsweremapped to themm9mouse genomeusing the
mapreads algorithm (Applied Biosystems). In order to maximize
the number of mappable reads we removed the final 5 nt for un-
mapped reads in a recursive strategy until the reads reached 25 nt
in length, similar to an approach previously described (Cloonan
et al. 2009). We recovered 17,438,921 and 47,356,494 unique
reads (defined by a unique sequencing read start site) that map-
ped exactly once to the mm9 genome for the KLF1 ChIP-seq and
Input DNA libraries, respectively.
KLF1 ChIP-seq peak detection
We employed the samemethod used by Chen et al. (2008) in order
to declare a set of KLF1-bound regions for downstream analysis.
When generating the tag intensity profile used in peak declaration,
we added a count of one to each position up to 100 bp 39 from the
start of each tag. To be declared a peak, a genomic position must
pass both a tag intensity threshold and a fold-change threshold.
We applied a false discovery rate (FDR) threshold of 1%, which
resulted in a tag intensity profile threshold of nine. We applied
negative control tag library fold-change threshold of 5.0 at the
center of each declared peak, yielding the final set of 945 declared
peaks.We additionally declared a less stringent set of 1380 peaks by
applying a fold-change threshold of 3.0 (Supplemental Table S1).
Motif analyses
We used several motif analysis tools to study the relationship
between KLF1 binding and transcription factor DNA-binding se-
quence specificity.
Average motif affinity (AMA) (Buske et al. 2010) was used to
estimate the fraction of regions around peaks that have a non-
randomly strong KLF1 affinity as predicted by a CACC box PWM.
The de novo motif discovery tool MEME (Bailey 2002) was
used to determineKLF1DNA-binding sequence specificitywithout
prior information.
We used the tool Clover (Frith et al. 2004) to measure en-
richment of knownmotifs in sets of KLF1 ChIP-seq peak regions of
interest, in order to identify motifs of possible co-binding tran-
scription factors. This was necessary in order to detect enrichments
that are invisible to de novo discovery, due to the inherently large
search space of de novo discovery.
We used SpaMo (T Whitington, MC Frith, and TL Bailey, in
prep.) to detect significant spacing relationships between known
motifs.
For the methodology and parameters employed when run-
ning these programs, refer to the Supplemental Methods.
Inference of KLF1-DNA-GATA1 ternary complex structure
The enriched motif spacing information inferred using SpaMo
allowed us to predict the likely structure of the corresponding
KLF1-DNA-GATA1 ternary complex, using existing transcription
factor-DNA X-ray crystallography structures. See Supplemental
Methods for an explanation of this approach.
Comparing KLF1 binding and transcriptional response
to perturbation of KLF1
To investigate the relationship between in vivo KLF1 binding and
transcriptional response to pertubation of Klf1, we compared our
ChIP-seq data with Klf1/ expression profiling data from primary
fetal liver (Hodge et al. 2006). Refer to Supplemental Methods for
an explanation of this analysis.
K1-ER cell line induction
K1-ER cells (Coghill et al. 2001) were maintained and treated with
4-hydroxytamoxifen (Tam; Sigma) or vehicle control (EtOH) as
previously described (Keys et al. 2007). The assessment of induced
KLF1 erythroid regulatory networks
Genome Research 1061
www.genome.org
specific changes in gene expression was performed as described
below.
Gene expression profiling by qRT-PCR
Fetal liver or K1-ER cell line RNA was isolated and used to produce
cDNA as described in the Supplemental Methods. Gene expression
profiling was performed by qRT-PCR using specific primer sets as
described in the Supplemental Methods and Supplemental Table S6.
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